Cyclerion Therapeutics (CYCN) Research & Development (2018 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Research & Development of $348000.0 for Q3 2025, up 329.63% year-over-year from $81000.0 in Q3 2024, and up 521.43% quarter-over-quarter from $56000.0 in Q2 2025.
Cyclerion Therapeutics (CYCN) Research & Development (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Research & Development history runs 8 years deep, the most recent figure standing at $348000.0 for Q3 2025.
- In Q3 2025, Research & Development rose 329.63% year-over-year to $348000.0; the TTM figure through Sep 2025 stood at $496000.0 (up 95.28% YoY), while the FY2024 annual figure was $286000.0, down 81.12% from the prior year.
- Research & Development for Q3 2025 stood at $348000.0, up from $56000.0 in the prior quarter.
- The five-year high for Research & Development was $12.1 million in Q2 2021, with the low at $24000.0 in Q4 2023.
- The 5-year median for Research & Development is $572000.0 (2023), against an average of $3.3 million.
- The sharpest annual moves came in 2023 and 2025: Research & Development plunged 97.96% in 2023, then jumped 329.63% in 2025.
- Cyclerion Therapeutics' Research & Development stood at $10.5 million in 2021, then plunged by 88.76% to $1.2 million in 2022, then slumped by 97.96% to $24000.0 in 2023, then soared by 133.33% to $56000.0 in 2024, then soared by 521.43% to $348000.0 in 2025.
- Business Quant data shows CYCN's Research & Development at $348000.0 in Q3 2025, $56000.0 in Q2 2025, and $36000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 413.13 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -588.31 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 210.03 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 97.90 Mn |
| 10 | Cyclerion Therapeutics | 12.38 Mn | 9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 580,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 572,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 10.22 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 10.46 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 12.05 Mn |
| Mar 31, 2021 | 8.09 Mn |
| Dec 31, 2020 | 12.09 Mn |